Still’s Disease: Research and Clinical Trials

The following webinar took place back on August 31st, 2021 in honor of Autoinflammatory Awareness Month and Still’s Disease Awareness Day (Sept 7). Nonprofit supporters included International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis), Systemic JIA Foundation, and the Autoinflammatory Alliance. Financial support was provided by Sobi and Avalo Therapeutics.

Current study opportunities

  • Sobi (MAS): Evaluate Efficacy, Safety and Tolerability, PK and PD, of Emapalumab in Children and Adults With MAS in Still’s or SLE (link)
  • Avalo Therapeutics (IL-18): A Study to Evaluate AEVI-007 in Participants With Adult-Onset Still’s Disease (link)

AiArthritis also shared two PDFs in a recent email –

Learn more about AiArthritis’ Still’s Disease work.